Rachel Keller

11PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 18, 2026
Turnaround Time of Comprehensive Genomic Profiling in Lung Cancer and Other Solid Tumors.

|Jul 23, 2025
ClinVar Database Evolution and Impact on Potential Pathogenic Germline Variant Reporting from Tumor Comprehensive Genomic Profiling.

Allison W Kurian, Erica Gornstein, Lisa Heppler

|Apr 03, 2025
Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid Tumors.

Dazhi Liu, Justin Jee, Alexander Drilon

|Aug 28, 2024
Breadth versus depth: whole transcriptome sequencing has reduced sensitivity for detection of clinically relevant fusions compared to RNA comprehensive genomic profiling.

Rachel B Keller-Evans, Daniela Munafo, Tristen Ross

|Aug 11, 2023
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing.

Nadine Tung, Kali Chatham Dougherty, Emily Stern Gatof

|Jul 18, 2023
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer.

Harshabad Singh, Rachel B Keller, Kevin S Kapner

Pageof 2

Frequent Collaborators

3 joint publications

Richard S P Huang

3 joint publications

Geoffrey I Shapiro

3 joint publications

Jason L Hornick

2 joint publications

Atul B Shinagare